Arthritis is a broad clinical term denoting inflammation of one or more joints, characterized by the cardinal signs of rubor, calor, dolor, and tumor — redness, warmth, pain, and swelling — often accompanied by progressive loss of joint function and range of motion. It is distinguished from arthralgia, which denotes joint pain without objective evidence of inflammation, and from arthrosis, a term historically used for non-inflammatory degenerative joint disease, though the boundary blurs considerably in late-stage osteoarthritis (M15-M19). The underlying mechanism varies by etiology: autoimmune forms such as rheumatoid arthritis (M05-M06) involve synovial membrane hyperplasia driven by cytokine-mediated immune dysregulation, whereas crystal-induced forms such as gout (M10) result from monosodium urate deposition triggering neutrophil-mediated acute inflammation. Arthritis may be physiological only in a trivial developmental sense; in virtually all clinical presentations it represents a pathological process, ranging from acute infectious arthritis (M00) to chronic degenerative osteoarthritis (M15-M19) and systemic autoimmunepolyarthritis. Clinically relevant subtypes encountered in inpatient coding include infectious/septic arthritis (M00-M02), rheumatoid arthritis with and without rheumatoid factor (M05-M06), crystal arthropathies including gout and pseudogout (M10-M11), psoriatic arthritis (L40.5x, M07.x), and primary osteoarthritis (M15-M19). It is commonly confused with bursitis (M70-M71) and tendinitis (M75-M77), which involve periarticular structures rather than the joint space itself, and with fibromyalgia (M79.7), which produces diffuse musculoskeletal pain without true joint inflammation.
Greek -ῖτις (-itis), from feminine of adjective suffix -itēs
Noun-forming suffix — “inflammation of,” “disease of” — standard medical suffix denoting an inflammatory condition of the named structure
The word entered English in the 1540s as arthritis (noun), borrowed directly from Latin arthritis, from Greek ἀρθρῖτις (arthrītis) — literally “disease of the joints.” The root arthr- (“joint”) connects arthritis to the entire -arthr- root family: arthroscopy (arthr- + -skopein → visual examination of a joint), arthrodesis (arthr- + -desis → surgical fusion of a joint), and arthroplasty (arthr- + -plasty → surgical repair or replacement of a joint). The suffix-itis is among the most productive in medical terminology, appearing in osteomyelitis, synovitis, tenosynovitis, bursitis, and peritonitis.
🔀 ALIASES / ALTERNATE TERMS
Arthritic(adjective form — common clinical collocations include “arthritic joint,” “arthritic changes on imaging,” and “arthritic flare”)
Arthropathy(broader clinical synonym encompassing both inflammatory and non-inflammatory joint disease; frequently appears in documentation for psoriatic arthropathy, crystal arthropathy, and neuropathic arthropathy — coded under M07.x, M11.x, M14.x depending on etiology)
Polyarthritis(simultaneous involvement of five or more joints; coded under M13.0 when etiology is unspecified; triggers more specific autoimmune workup)
Oligoarthritis(involvement of two to four joints; commonly used in pediatric rheumatology and early psoriatic arthritis documentation)
Septic arthritis(acute infectious form caused by bacterial hematogenous seeding or direct inoculation of the joint space; M00.x — site and laterality required)
Rheumatoid arthritis(systemic autoimmune synovitis with seropositive (M05.x) and seronegative (M06.x) subtypes; high-priority inpatient diagnosis with significant CC/MCC capture potential)
Osteoarthritis(degenerative, non-primarily-inflammatory form characterized by cartilage breakdown and subchondral bone changes; primary forms M15-M19 by site; secondary forms M19.2x)
Crystal arthropathy(acute or chronic arthritis triggered by crystal deposition — monosodium urate in gout (M10.x), calcium pyrophosphate in pseudogout/CPPD (M11.x))
Psoriatic arthritis(inflammatory arthritis associated with psoriasis; coded under M07.x when psoriatic etiology is documented; requires L40.5x dual-coding per convention)
Reactive arthritis(post-infectious sterile joint inflammation following GI or GU infection; M02.x — site required; formerly called Reiter syndrome)
Neuropathic arthropathy(Charcot joint — destructive arthropathy secondary to loss of protective sensation; M14.6x — most common in diabetic neuropathy)
Juvenile idiopathic arthritis(onset before age 16; M08.x — includes systemic, oligoarticular, and polyarticular subtypes)
🔗 RELATED TERMS
arthralgia — joint pain without objective inflammatory signs; distinguished from arthritis by the absence of swelling, warmth, or synovial effusion; coded separately under M25.5x when no underlying arthritis diagnosis is documented
synovitis — inflammation limited to the synovial membrane lining the joint; may precede or accompany full arthritis; coded under M65.x or M67.2x depending on site and acuity
bursitis — inflammation of the fluid-filled bursa sac adjacent to joints; shares the -itis suffix; coded under M70-M71 and distinguished from arthritis by the periarticular rather than intra-articular location
osteoarthritis — the most common form of joint disease, characterized by progressive cartilage degradation, subchondral sclerosis, and osteophyte formation; while not primarily inflammatory, secondary synovitis frequently develops (M15-M19)
rheumatoid arthritis — the prototypical autoimmune inflammatory arthritis; systemic disease with extra-articular manifestations including rheumatoid nodules, interstitial lung disease, and vasculitis (M05.x seropositive, M06.x seronegative)
gout — acute crystal arthritis caused by monosodium urate crystal deposition, classically in the first MTP joint (podagra); M10.x — requires site specificity and coding of associated hyperuricemia (E79.0) when documented
pannus — the invasive proliferating synovial tissue that erodes cartilage and bone in rheumatoid arthritis; key pathological mechanism differentiating RA from degenerative forms
synovial fluid analysis — the primary diagnostic procedure for differentiating septic, crystal, and inflammatory arthritis; guides coding specificity, particularly for M00 vs. M10 vs. M13 selection
ankylosing spondylitis — seronegative spondyloarthropathy primarily affecting the axial skeleton and sacroiliac joints; belongs to the broader arthritis family but coded under M45.x
fibromyalgia — diffuse musculoskeletal pain syndrome commonly confused with inflammatory polyarthritis; lacks joint swelling or elevated inflammatory markers; M79.7
erosive arthritis — radiographic descriptor indicating bone erosion at joint margins, most characteristic of RA and psoriatic arthritis; documentation of “erosive” changes supports specificity in code selection
MRI of joint — key advanced imaging modality for evaluating synovitis, cartilage integrity, and erosive changes not visible on plain radiograph
CODING CORNER
🏥 ICD-10-CM CODES
Infectious Arthritis | Septic Arthritis (M00.x — Site and Laterality Required)
⚠️ Coding Note:ICD-10-CM arthritis codes require site specificity and laterality at the highest available level of specificity — unspecified codes (e.g., M13.9, M17.9) should only be used when the operative or clinical documentation genuinely fails to identify the joint or side despite query. Sequencing logic depends on etiology: when arthritis is due to an underlying systemic condition (e.g., gout with hyperuricemia E79.0, psoriasis L40.x), the convention is to code the arthritis manifestation first per Index direction and add the underlying condition as an additional code. A common undercoding alert on inpatient profee claims is failure to capture septic arthritis (M00.x) at a specific organism level — documentation of a joint infection with a known organism cultured from synovial fluid or blood culture should prompt specificity to the organism-level code rather than defaulting to M00.9; query language to use: “Does the clinical picture support septic/infectious arthritis due to [organism]?” Payer-specific considerations for rheumatoid arthritis include the seropositive (M05.x) vs. seronegative (M06.x) distinction, which may affect prior authorization for biologics; document RF and anti-CCP status explicitly. When gout is coded, always evaluate for concurrent E79.0 (hyperuricemia) and N20.0 (nephrolithiasis) as additional diagnoses, as these significantly affect DRG weight and represent legitimate comorbidity capture opportunities.